Danazol.

The American journal of medicine · 1989 · vol. 87(3N) , pp. 49N–55N · PMID:2486535 · W4290284667
article OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed

Abstract

Danazol is a synthetic attenuated androgen that can interfere with normal interactions between the pituitary-hypothalamic axis and the gonads. These effects are mediated by complex mechanisms, including those in which danazol can compete with natural steroids in binding to androgen receptors or to sex hormone-binding globulin, possibly displacing natural steroids from this protein, and in binding to reactive sites of enzymes required for synthesis of natural steroids, thereby depressing synthesis. Because of danazol's impairment of the pituitary-hypothalamic interactions with gonads, it is an effective therapeutic agent for treatment of endometriosis and cystic disease of the breast. It is effective in the treatment of hereditary angioneurotic edema, but the mechanism of this therapeutic success is unclear. Danazol has been used, without universal success, in the treatment of other gynecologic and certain hematologic disorders.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Danazol Gonads Hypothalamus Pituitary Gland Blood Proteins Blood Proteins Danazol Danazol Danazol Gonads Hematologic Diseases Hematologic Diseases Humans Hypothalamus Pituitary Gland

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

Cited by (2)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:09:10.744835+00:00
License: CC0 · commercial use OK